RE Dickinson Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$35.5K Sell
46
-250
-84% -$207K 0.02% 106
2024
Q3
$262K Buy
296
+1
+0.3% +$899 0.15% 41
2024
Q2
$267K Buy
295
+2
+0.7% +$1.6K 0.16% 40
2024
Q1
$228K Hold
293
0.14% 43
2023
Q4
$171K Buy
293
+5
+2% +$2.92K 0.11% 45
2023
Q3
$155K Hold
288
0.11% 48
2023
Q2
$135K Hold
288
0.05% 102
2023
Q1
$99K Hold
288
0.03% 122
2022
Q4
$105K Hold
288
0.04% 108
2022
Q3
$93K Hold
288
0.08% 55
2022
Q2
$93K Hold
288
0.01% 56
2022
Q1
$82K Hold
288
0.06% 68
2021
Q4
$80K Buy
+288
New +$73K 0.06% 59

Other funds holding LLY

RE Dickinson Investment Advisors's LLY Position: Q4 2024 in Review

RE Dickinson Investment Advisors reduced its Eli Lilly (LLY) stake by 84% in Q4 2024, selling an estimated $207K and leaving 46 shares worth $35.5K. The position accounts for 0.02% of the portfolio, ranked #106.

RE Dickinson Investment Advisors first reported a position in LLY in Q4 2021 and has held it in 13 quarters since. The position peaked at $267K in Q2 2024. 3,913 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • RE Dickinson Investment Advisors held 46 shares of Eli Lilly worth $35.5K as of Q4 2024.
  • RE Dickinson Investment Advisors sold 250 Eli Lilly shares in Q4 2024, an estimated $207K.
  • Eli Lilly made up 0.02% of RE Dickinson Investment Advisors's portfolio in Q4 2024, its #106 holding.
  • RE Dickinson Investment Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 13 quarters since.
  • RE Dickinson Investment Advisors's Eli Lilly position peaked at $267K in Q2 2024.
  • 3,913 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on RE Dickinson Investment Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.